Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 19946270)

1.

Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies.

Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA.

Nat Genet. 2010 Jan;42(1):77-82. doi: 10.1038/ng.491. Epub 2009 Nov 29.

2.

Contribution of germline mutations to PARK2 gene inactivation in lung adenocarcinoma.

Iwakawa R, Okayama H, Kohno T, Sato-Otsubo A, Ogawa S, Yokota J.

Genes Chromosomes Cancer. 2012 May;51(5):462-72. doi: 10.1002/gcc.21933. Epub 2012 Feb 3.

PMID:
22302706
3.

PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.

Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH, Ichimura K, Luo F, Cantley LC, Wyllie AH, Adams DJ, Arends MJ.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15145-50. doi: 10.1073/pnas.1009941107. Epub 2010 Aug 9.

4.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
5.

The familial Parkinson disease gene PARK2 is a multisite tumor suppressor on chromosome 6q25.2-27 that regulates cyclin E.

Veeriah S, Morris L, Solit D, Chan TA.

Cell Cycle. 2010 Apr 15;9(8):1451-2. Epub 2010 Apr 15. No abstract available.

6.

PARK2 gene mutations in early onset Parkinson's disease patients of South India.

Padmaja MV, Jayaraman M, Srinivasan AV, Srisailapathy CR, Ramesh A.

Neurosci Lett. 2012 Aug 15;523(2):145-7. doi: 10.1016/j.neulet.2012.06.062. Epub 2012 Jul 3.

PMID:
22766139
7.

An emerging role of PARK2 in cancer.

Xu L, Lin DC, Yin D, Koeffler HP.

J Mol Med (Berl). 2014 Jan;92(1):31-42. doi: 10.1007/s00109-013-1107-0. Epub 2013 Dec 3. Review.

PMID:
24297497
8.

Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.

Shadrina MI, Semenova EV, Slominsky PA, Bagyeva GH, Illarioshkin SN, Ivanova-Smolenskaia II, Limborska SA.

BMC Med Genet. 2007 Feb 26;8:6.

9.

Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.

Aguiar Pde C, Lessa PS, Godeiro C Jr, Barsottini O, Felício AC, Borges V, Silva SM, Saba RA, Ferraz HB, Moreira-Filho CA, Andrade LA.

Mov Disord. 2008 Jul 15;23(9):1228-33. doi: 10.1002/mds.22032.

PMID:
18464276
10.

Low frequency of the PARK2 gene mutations in Polish patients with the early-onset form of Parkinson disease.

Koziorowski D, Hoffman-Zacharska D, Sławek J, Szirkowiec W, Janik P, Bal J, Friedman A.

Parkinsonism Relat Disord. 2010 Feb;16(2):136-8. doi: 10.1016/j.parkreldis.2009.06.010. Epub 2009 Jul 22.

PMID:
19628420
11.

Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.

Hertz JM, Ostergaard K, Juncker I, Pedersen S, Romstad A, Møller LB, Güttler F, Dupont E.

Eur J Neurol. 2006 Apr;13(4):385-90.

PMID:
16643317
12.

Structure of parkin reveals mechanisms for ubiquitin ligase activation.

Trempe JF, Sauvé V, Grenier K, Seirafi M, Tang MY, Ménade M, Al-Abdul-Wahid S, Krett J, Wong K, Kozlov G, Nagar B, Fon EA, Gehring K.

Science. 2013 Jun 21;340(6139):1451-5. doi: 10.1126/science.1237908. Epub 2013 May 9.

13.

Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early-onset Parkinson disease.

Kim SY, Seong MW, Jeon BS, Kim SY, Ko HS, Kim JY, Park SS.

Clin Genet. 2012 Jul;82(1):77-82. doi: 10.1111/j.1399-0004.2011.01693.x. Epub 2011 May 29.

PMID:
21534944
14.

Genetic analysis of PARK2 and PINK1 genes in Brazilian patients with early-onset Parkinson's disease.

Moura KC, Campos Junior M, de Rosso AL, Nicaretta DH, Pereira JS, Silva DJ, dos Santos FL, Rodrigues Fda C, Santos-Rebouças CB, Pimentel MM.

Dis Markers. 2013;35(3):181-5. doi: 10.1155/2013/597158. Epub 2013 Aug 14.

15.

PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease.

Chan DK, Mok V, Ng PW, Yeung J, Kwok JB, Fang ZM, Clarke R, Wong L, Schofield PR, Hattori N.

J Neural Transm. 2008 May;115(5):715-9. doi: 10.1007/s00702-007-0011-6. Epub 2008 Jan 11.

PMID:
18188499
16.

Somatic mutation of PARK2 tumor suppressor gene is not common in common solid cancers.

Je EM, Yoo NJ, Lee SH.

Pathol Oncol Res. 2013 Jul;19(3):393-5. doi: 10.1007/s12253-012-9591-z. Epub 2012 Dec 8.

PMID:
23225159
17.

Parkin-associated Parkinson's disease.

von Coelln R, Dawson VL, Dawson TM.

Cell Tissue Res. 2004 Oct;318(1):175-84. Epub 2004 Jul 30. Review.

PMID:
15503153
18.

PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Gaweda-Walerych K, Safranow K, Jasinska-Myga B, Bialecka M, Klodowska-Duda G, Rudzinska M, Czyzewski K, Cobb SA, Slawek J, Styczynska M, Opala G, Drozdzik M, Nishioka K, Farrer MJ, Ross OA, Wszolek ZK, Barcikowska M, Zekanowski C.

Parkinsonism Relat Disord. 2012 Jun;18(5):520-4. doi: 10.1016/j.parkreldis.2012.01.021. Epub 2012 Feb 22.

19.

Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease.

Chu MK, Kim WC, Choi JM, Hong JH, Kang SY, Ma HI, Kim YJ.

J Clin Neurol. 2014 Jul;10(3):244-8. doi: 10.3988/jcn.2014.10.3.244. Epub 2014 Jul 3. Erratum in: J Clin Neurol. 2015 Jan;11(1):107.

20.

A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

Abbas N, Lücking CB, Ricard S, Dürr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, Oostra BA, Fabrizio E, Böhme GA, Pradier L, Wood NW, Filla A, Meco G, Denefle P, Agid Y, Brice A.

Hum Mol Genet. 1999 Apr;8(4):567-74.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk